Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Repeated Echocardiographic Left Ventricular Ejection Fraction Measurements: A Strong and Accessible Tool for Detecting At High Risk of Heart Failure Thalassemia Major Population,

Blood (2011) 118 (21): 3197.

https://doi.org/10.1182/blood.V118.21.3197.3197

Published: 2011

Journal Articles

Prospective Comparison on Cardiac and Hepatic Iron and Cardiac Function by MR in Thalassemia Major Patients Treated with Combination Deferiprone–Desferrioxamine Versus Deferiprone and Desferrioxamine in Monoterapy,

Alessia Pepe, Antonella Meloni, PhD, Pasquale Pepe, Marcello Capra, M.D., Domenico Giuseppe D'Ascola, Michele Santodirocco, Paolo Cianciulli, M.D., Vincenzo Caruso, M.D., Maria Antonietta Romeo, M.D., Aldo Filosa, Lorella Pitrolo, Maria Caterina Putti, MD, Aurelio Maggio, MD, Massimiliano Missere, Vincenzo Positano, Massimo Lombardi, Paolo Ricchi

Blood (2011) 118 (21): 3194.

https://doi.org/10.1182/blood.V118.21.3194.3194

Published: 2011

Journal Articles

A MRI Prospective Survey on Cardiac and Hepatic Iron and Cardiac Function in Thalassemia Major Patients Treated with Sequential deferiprone–desferrioxamine versus Deferasirox

Alessia Pepe, Antonella Meloni, PhD, Giuseppe Rossi, Domenico Giuseppe D'Ascola, Marcello Capra, M.D., Aldo Filosa, Paolo Cianciulli, M.D., Luciano Prossomariti, Antonella Quarta, M.D., Tommaso Casini, Maria Grazia Bisconte, Saveria Campisi, Aurelio Maggio, MD, Cristina Salvatori, Massimo Midiri, Massimo Lombardi, Caterina Borgna-Pignatti

Blood (2011) 118 (21): 1087.

https://doi.org/10.1182/blood.V118.21.1087.1087

Published: 2011

Journal Articles

Heart T2* for Prediction of Cardiac Complications in Well-Treated TM Patients

Alessia Pepe, Antonella Meloni, PhD, Giuseppe Rossi, Paolo Cianciulli, M.D., Anna Spasiano, Domenico D'Ascola, Aurelio Maggio, MD, Domenico Maddaloni, Antonella Carollo, M.D., Michele Rizzo, M.D., Ketty Perrotta, M.D., Giuseppina Secchi, Maria Eliana Lai, Vincenzo Positano, Massimo Lombardi

Blood (2011) 118 (21): 1089.

https://doi.org/10.1182/blood.V118.21.1089.1089

Published: 2011

Journal Articles

Diabetes Mellitus and Cardiac Complications in Thalassemia Major Patients

Maria Rita Gamberini, Antonella Meloni, PhD, Vincenzo Caruso, M.D., Marcello Capra, M.D., Paolo Cianciulli, M.D., Aurelio Maggio, MD, Elisabetta Chiodi, Massimo Lombardi, Alessia Pepe

Blood (2011) 118 (21): 2150.

https://doi.org/10.1182/blood.V118.21.2150.2150

Published: 2011

Journal Articles

Onset of Cardiac Iron Loading in a Large and Homogeneous Cohort of Thalassemia Major Paediatric Patients

Alessia Pepe, Antonella Meloni, PhD, Brunella Favilli, Marcello Capra, M.D., Domenico Giuseppe D'Ascola, Giovanni Palazzi, Antonella Quarta, M.D., Tommaso Casini, Maria Caterina Putti, MD, Paolo Cianciulli, M.D., Lucia De Franceschi, MD, Vincenzo Positano, Daniele De Marchi, Massimo Lombardi, Aldo Filosa

Blood (2011) 118 (21): 2157.

https://doi.org/10.1182/blood.V118.21.2157.2157

Published: 2011

Journal Articles

Prospective Survey on Heart and Liver Iron and Heart Function in Thalassemia Major Patients Treated with Sequential deferiprone–desferrioxamine Versus Deferiprone and Desferrioxamine in Monotherapy

Alessia Pepe, Antonella Meloni, PhD, Giuseppe Rossi, Anna Spasiano, Domenico Giuseppe D'Ascola, Aldo Filosa, Vincenzo Caruso, M.D., Paolo Cianciulli, M.D., Maria Antonietta Romeo, M.D., Maria Caterina Putti, MD, Angelo Peluso, Maria Grazia Bisconte, Maria Eliana Lai, Aurelio Maggio, MD, Cristina Salvatori, Massimo Lombardi, Marcello Capra, M.D.

Blood (2011) 118 (21): 5298.

https://doi.org/10.1182/blood.V118.21.5298.5298

Published: 2011

Journal Articles

Long-Term Use of Deferiprone Enhances Significantly the Left Ventricular Ejection Function in Thalassemia Major

Blood (2011) 118 (21): 5302.

https://doi.org/10.1182/blood.V118.21.5302.5302

Published: 2011

Journal Articles

Deferiprone Versus Sequential Deferiprone-Deferoxamine Treatment in Thalassemia Major: A Five Years Multicenter Randomized Clinical Trial under the Auspices of the Society for the Study of Thalassemia and Hemoglobinopathies (SoSTE).

Blood (2007) 110 (11): 575.

https://doi.org/10.1182/blood.V110.11.575.575

Published: 2007

NARROW

Repeated Echocardiographic Left Ventricular Ejection Fraction Measurements: A Strong and Accessible Tool for Detecting At High Risk of Heart Failure Thalassemia Major Population,

Prospective Comparison on Cardiac and Hepatic Iron and Cardiac Function by MR in Thalassemia Major Patients Treated with Combination Deferiprone–Desferrioxamine Versus Deferiprone and Desferrioxamine in Monoterapy,

A MRI Prospective Survey on Cardiac and Hepatic Iron and Cardiac Function in Thalassemia Major Patients Treated with Sequential deferiprone–desferrioxamine versus Deferasirox

Heart T2* for Prediction of Cardiac Complications in Well-Treated TM Patients

Diabetes Mellitus and Cardiac Complications in Thalassemia Major Patients

Onset of Cardiac Iron Loading in a Large and Homogeneous Cohort of Thalassemia Major Paediatric Patients

Prospective Survey on Heart and Liver Iron and Heart Function in Thalassemia Major Patients Treated with Sequential deferiprone–desferrioxamine Versus Deferiprone and Desferrioxamine in Monotherapy

Long-Term Use of Deferiprone Enhances Significantly the Left Ventricular Ejection Function in Thalassemia Major

Deferiprone Versus Sequential Deferiprone-Deferoxamine Treatment in Thalassemia Major: A Five Years Multicenter Randomized Clinical Trial under the Auspices of the Society for the Study of Thalassemia and Hemoglobinopathies (SoSTE).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only